Intellipharmaceutics International Inc. (IPCI)

[Tekterra]

I would say Odidi absolutely did a poor job here. Not that he didn't deliver some last year but I don't agree with his running the ship under a tight budget.

He knew well ahead of time that Rexista and continual generic development is going to require more funding. In a way he was putting the company and share holders under unnecessary risk.

To run a successful company you're going to need a strong balance sheet with ample cash. He could have raised capital when we were running in the 3$. Give himself that cushion if Rexista delays and revenue don't come in fast enough. He could even start that PODRAS trial we've been hearing about.

It's like you're trying to run your family financials but you're only keeping 300$ cash on hand. You run into any unexpected expenses, you're likely going broke in a bad way.

I know we have talked about this in the past. I would rather see us with 20 million cash and being able to move things forward faster. I would hope he learn from past mistakes.

IPCI's goal shouldn't be to break even. It should be focused in unlocking PODRAS and the NDAs. We've heard nothing of starting PODRAS trails since we last hear about it earlier this year. I mentioned, that's what I really look forward too, and it would seems like a big let down.

I guess I'll check back another time to see if any interesting development.